Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide-Reference-Cited by-同舟云学术

Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide

Published:2012-07-20 Issue:21 Volume:30 Page:e180-e183
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Stuplich Moritz¹,Hadizadeh Dariusch R.¹,Kuchelmeister Klaus¹,Scorzin Jasmin¹,Filss Christian²,Langen Karl-Josef²,Schäfer Niklas¹,Mack Frederic¹,Schüller Heinrich¹,Simon Matthias¹,Glas Martin¹,Pietsch Torsten¹,Urbach Horst¹,Herrlinger Ulrich¹

Affiliation:

1. University of Bonn Medical Center, Bonn, Germany

2. German Institute of Neuroscience and Medicine, Juelich, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.40.9565

Reference11 articles.

1. MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

2. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas